court decision on tirzepatide Lilly Takes Four Compounders to for Allegedly Producing Knockoff Lilly asks to join lawsuit

Aggarwal V, Tuli HS, Varol A, Thakral F, Yerer MB, Sak K, Varol M, Jain A, Khan MdA, Sethi G

It is being evaluated in Phase 3 trials for obesity and type 2 diabetes

We also specialize in male and female hormone evaluation & replacement

Updated July 2026 Drug comparisons See all Retatrutide vs Tirzepatide (Zepbound): Triple Agonist vs Dual Agonist Retatrutide produces 28.7% weight loss (triple agonist) vs tirzepatide's 22.5% (dual agonist)

'Why wouldn't I give her the tool that she would need to do that?' And it turns out Kait is not alone in encouraging her child to take weight loss drugs

We can see now that the modus operandi of the counterfeiters [is] more and more sophisticated